| Quarterly Financials | Dec 2020 | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 |
Revenue  | 15 | 31 | 37 | 34 | 31 | 28 | 27 | 27 | 20 | 30 | 25 | 26 | 27 | 28 | 30 | 40 | 29 | 34 | 35 | 35 | 36 |
| Expenses | 14 | 26 | 31 | 28 | 25 | 25 | 25 | 25 | 20 | 28 | 25 | 25 | 26 | 27 | 29 | 27 | 26 | 31 | 32 | 32 | 32 |
| EBITDA | 1 | 5 | 6 | 7 | 6 | 3 | 1 | 3 | 0 | 2 | 0 | 1 | 1 | 1 | 1 | 13 | 2 | 3 | 3 | 3 | 5 |
| Operating Profit % | 3 % | 15 % | 16 % | 18 % | 15 % | 7 % | 0 % | 6 % | -1 % | 6 % | -1 % | 1 % | 1 % | 3 % | 3 % | 7 % | 5 % | 9 % | 9 % | 7 % | 12 % |
| Depreciation | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Interest | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | -1 | 3 | 5 | 5 | 5 | 1 | -0 | 0 | -2 | 1 | -1 | -1 | -1 | -0 | -1 | 11 | 1 | 2 | 2 | 1 | 3 |
| Tax | 0 | 2 | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | -0 | 1 | 0 | 1 | 0 | 1 | 1 | 1 | 1 |
| Net Profit | -1 | 2 | 4 | 4 | 4 | 1 | -1 | 0 | -2 | 0 | -2 | -1 | -1 | -1 | -1 | 10 | 0 | 2 | 1 | 1 | 2 |
| EPS in ₹ | -2.24 | 0.45 | 3.69 | 3.54 | 4.13 | -1.24 | -2.82 | -1.00 | -3.65 | -0.43 | -3.55 | -2.27 | -2.61 | -2.18 | -1.67 | 14.94 | -0.50 | -0.08 | 0.74 | -0.20 | 1.59 |
Makers Laboratories
Makers Laboratories
148.00
+1.05
(0.71%)
Market Cap
87.32 Cr
PE Ratio
14.74
Volume
4,464.00
Day High - Low
153.95 - 146.00
52W High-Low
173.70 - 109.00
Key Fundamentals
Market Cap
87.32 Cr
EPS
12.70
PE Ratio
14.74
PB Ratio
1.23
Book Value
93.97
EBITDA
20.30
Dividend Yield
0.00 %
Industry
Healthcare Sector
Pharmaceuticals Return on Equity
9.47
Debt to Equity
0.22
Actual
Company News
View All News
Makers Laboratories Limited reported consolidated revenue of ₹3,566.76 lakhs for Q3FY26, up 28.8% YoY. Nine-month revenue reached ₹10,484.31 lakhs, marking 20.7% growth over previous year.
Makers Laboratories Limited has scheduled its Board of Directors meeting for February 10, 2026, to consider and approve Q3FY26 unaudited financial results. Trading window remains closed until February 12.
Makers Laboratories Limited reported a net loss of Rs 6.18 lakhs for the quarter ended September 30, 2025, compared to a profit of Rs 5.85 lakhs in the same period last year. Revenue from operations increased to Rs 167.67 lakhs from Rs 143.50 lakhs year-on-year. For the half-year period, the company posted a net loss of Rs 70.86 lakhs versus a profit of Rs 77.48 lakhs in the previous year. On a consolidated basis, the company reported a quarterly profit of Rs 74.70 lakhs compared to Rs 128.61 lakhs last year. The company operates in pharmaceutical and chemical manufacturing segments, with the pharmaceutical segment showing a loss while chemical manufacturing remained profitable. Total expenses increased significantly, impacting overall profitability despite revenue growth.
View more
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
1,724.40 | #1 4,13,741.32 | 37.53 | #1 54,729.00 | 9.71 | #1 10,980 | 16.07 | 58.16 | |
6,291.00 | 1,67,006.28 | 67.40 | 9,712.00 | 18.67 | 2,191 | -1.02 | 53.89 | |
4,241.70 | 1,43,558.40 | 62.90 | 11,539.40 | 6.99 | 1,911 | 26.24 | 66.58 | |
1,341.10 | 1,08,330.28 | 23.68 | 28,409.50 | 7.12 | 5,291 | -57.18 | 43.41 | |
1,280.40 | 1,06,866.07 | 19.34 | 33,741.20 | 16.73 | 5,725 | -15.28 | 60.10 | |
2,219.40 | 1,01,381.93 | 21.81 | 22,909.50 | 13.74 | 3,306 | #1 37.44 | 57.52 | |
900.75 | 90,636.53 | #1 18.06 | 23,511.00 | 18.55 | 4,615 | -0.32 | 49.52 | |
2,024.30 | 83,564.13 | 46.65 | 12,744.20 | #1 20.90 | 2,007 | 7.65 | 38.95 | |
1,158.80 | 67,303.29 | 19.60 | 32,345.60 | 9.43 | 3,484 | 7.59 | 47.48 | |
5,392.00 | 64,469.45 | 26.53 | 13,458.30 | 3.70 | 2,216 | 1.90 | 37.57 |
Growth Rate
Revenue Growth
25.21 %
Net Income Growth
-327.08 %
Cash Flow Change
-585.71 %
ROE
-305.42 %
ROCE
-833.54 %
EBITDA Margin (Avg.)
526.23 %
Quarterly Financial Results
Balance Sheet
| Balance Sheet | 2021 | 2022 | 2023 | 2024 | 2025 |
| Total Assets | 136 | 144 | 152 | 161 | 148 |
| Fixed Assets | 71 | 68 | 85 | 87 | 74 |
| Current Assets | 61 | 63 | 63 | 70 | 68 |
| Capital Work in Progress | 0 | 9 | 1 | 0 | 1 |
| Investments | 2 | 0 | 0 | 3 | 0 |
| Other Assets | 63 | 66 | 67 | 71 | 73 |
| Total Liabilities | 136 | 144 | 152 | 161 | 148 |
| Current Liabilities | 33 | 33 | 28 | 37 | 21 |
| Non Current Liabilities | 17 | 13 | 15 | 20 | 12 |
| Total Equity | 87 | 98 | 110 | 104 | 115 |
| Reserve & Surplus | 49 | 55 | 63 | 57 | 65 |
| Share Capital | 5 | 5 | 6 | 6 | 6 |
Cash Flow
| Cash Flow | 2021 | 2022 | 2023 | 2024 | 2025 |
| Net Cash Flow | 0 | -3 | -2 | -0 | -0 |
| Investing Activities | 0 | -22 | 1 | -7 | 20 |
| Operating Activities | 0 | 19 | -9 | 1 | -4 |
| Financing Activities | 0 | 0 | 6 | 6 | -16 |
Share Holding
| % Holding | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 |
| Promoter | 58.37 % | 58.37 % | 58.37 % | 58.37 % | 58.37 % | 61.27 % | 61.27 % | 61.27 % | 61.27 % | 61.27 % | 61.27 % | 61.27 % | 61.27 % | 61.27 % | 61.27 % | 61.27 % | 61.27 % | 61.27 % | 61.27 % | 61.27 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| DIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.39 % | 0.39 % | 0.00 % | 0.39 % | 0.39 % | 0.00 % | 0.39 % | 0.39 % | 0.39 % | 0.39 % | 0.39 % | 0.39 % | 0.39 % | 0.39 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 29.49 % | 29.45 % | 29.28 % | 30.60 % | 31.62 % | 29.57 % | 29.96 % | 29.98 % | 29.80 % | 29.73 % | 29.63 % | 29.65 % | 29.93 % | 30.54 % | 30.86 % | 30.67 % | 30.90 % | 31.01 % | 30.98 % | 31.20 % |
| Others | 12.14 % | 12.18 % | 12.35 % | 11.03 % | 10.01 % | 9.15 % | 8.38 % | 8.36 % | 8.93 % | 8.61 % | 8.70 % | 9.08 % | 8.40 % | 7.80 % | 7.48 % | 7.67 % | 7.43 % | 7.33 % | 7.36 % | 7.14 % |
| No of Share Holders | 3,914 | 3,943 | 3,937 | 4,075 | 4,667 | 4,753 | 4,839 | 4,621 | 4,483 | 4,402 | 4,283 | 4,179 | 4,176 | 4,090 | 4,008 | 4,031 | 4,135 | 4,073 | 4,026 | 3,926 |
Dividend History
| Annual Cash Flows | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Per Share (₹) | 1 | 1 | 1 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend Yield (%) | 1.42 | 1.98 | 3.5 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 01 Apr 2022 |  Rights | 1:5 | 30 Mar 2022 | 188.15 | 182.60 |
| 06 Aug 2024 |  Annual General Meeting | NA | 06 Aug 2024 | 133.55 | 167.75 |
| 29 Oct 2024 |  Quarterly Result Announcement | NA | 29 Oct 2024 | 151.05 | 144.15 |
| 29 Jan 2025 | Quarterly Result Announcement | NA | 29 Jan 2025 | 183.10 | 174.75 |
| 26 May 2025 | Quarterly Result Announcement | NA | 26 May 2025 | 135.30 | 159.30 |
| 08 Aug 2025 | Quarterly Result Announcement | NA | 08 Aug 2025 | 154.00 | 155.60 |
| 08 Aug 2025 | Annual General Meeting | NA | 08 Aug 2025 | 149.75 | 155.60 |
| 07 Nov 2025 | Quarterly Result Announcement | NA | 07 Nov 2025 | 132.55 | 129.35 |
| 10 Feb 2026 | Quarterly Result Announcement | NA | 10 Feb 2026 | 122.60 | 137.65 |
Announcements
Announcement under Regulation 30 (LODR)-Newspaper Publication
9 days ago
9 days agoStandalone And Consolidated Financial Results For 3Rd Quarter And Nine Months Ended 31.12.202510 days ago
10 days agoBoard Meeting Outcome for Standalone And Consolidated Financial Results For 3Rd Quarter And Nine Months Ended 31.12.202510 days ago
10 days agoRe-Lodgement Of Transfer Requests Report - November 2025 And December 2025Jan 21, 2026
Jan 21, 2026Board Meeting Intimation for Standalone And Consolidated Financial Results For 3Rd Quarter And Nine Months Ended 31St December 2025Jan 21, 2026
Jan 21, 2026Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 08, 2026
Jan 08, 2026Closure of Trading WindowDec 22, 2025
Dec 22, 2025Re-Lodgement Of Transfer Requests Of Physical Shares Report - October 2025Nov 18, 2025
Nov 18, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 10, 2025
Nov 10, 2025Standalone And Consolidated Financial Results For Q2 And Half Year Ended 30.09.2025Nov 07, 2025
Nov 07, 2025Board Meeting Outcome for Standalone And Consolidated Financial Results For Q2 And Half Year Ended 30.09.2025Nov 07, 2025
Nov 07, 2025Board Meeting Intimation for Standalone And Consolidated Unaudited Financial Results For The 2Nd Quarter And Half Year Ended 30.09.2025Oct 16, 2025
Oct 16, 2025Relodgement Of Transfer For Physical Shares - Sep 2025Oct 10, 2025
Oct 10, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Oct 09, 2025
Oct 09, 2025Closure of Trading WindowSep 25, 2025
Sep 25, 2025Relodgement Of Transfer Requests Of Physical Shares - July 2025 And August 2025Sep 10, 2025
Sep 10, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationSep 10, 2025
Sep 10, 2025Announcement under Regulation 30 (LODR)-Credit RatingAug 29, 2025
Aug 29, 2025Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Aug 22, 2025
Aug 22, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 11, 2025
Aug 11, 2025Shareholder Meeting / Postal Ballot-Scrutinizers ReportAug 08, 2025
Aug 08, 2025Announcement under Regulation 30 (LODR)-Change in ManagementAug 08, 2025
Aug 08, 2025Shareholder Meeting / Postal Ballot-Outcome of AGMAug 08, 2025
Aug 08, 2025Standalone And Consolidated Unaudited Financial Results For Q1FY26Aug 08, 2025
Aug 08, 2025Board Meeting Outcome for Standalone And Consolidated Unaudited Financial Results For Q1FY26Aug 08, 2025
Aug 08, 2025Board Meeting Intimation for Standalone And Consolidated Financial Results For Q1FY26Jul 25, 2025
Jul 25, 2025Intimation To Shareholders Whose E-Mail Ids Are Not Registered With The Company / RTA / DPJul 14, 2025
Jul 14, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 10, 2025
Jul 10, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 10, 2025
Jul 10, 202540Th Annual General Meeting Of The Company To Be Held On Friday 8Th August 2025Jul 09, 2025
Jul 09, 2025Reg. 34 (1) Annual Report.Jul 09, 2025
Jul 09, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 02, 2025
Jul 02, 2025Closure of Trading WindowJun 23, 2025
Jun 23, 2025Change In The Name Of Statutory Audit FirmJun 16, 2025
Jun 16, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationJun 05, 2025
Jun 05, 2025Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 28, 2025
May 28, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 27, 2025
May 27, 2025Announcement under Regulation 30 (LODR)-Change in ManagementMay 26, 2025
May 26, 2025Standalone And Consolidated Q4FY25 ResultsMay 26, 2025
May 26, 2025Board Meeting Outcome for Standalone And Consolidated Q4FY25 ResultsMay 26, 2025
May 26, 2025Board Meeting Intimation for Standalone And Consolidated Audited Financial Results For Q4 And FY25May 13, 2025
May 13, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 07, 2025
Apr 07, 2025Closure of Trading WindowMar 26, 2025
Mar 26, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationJan 30, 2025
Jan 30, 2025Integrated Filing (Financial)Jan 29, 2025
Jan 29, 2025Standalone And Consolidated Q3FY25 Unaudited Financial ResultsJan 29, 2025
Jan 29, 2025Board Meeting Outcome for Standalone And Consolidated Q3FY25 Unaudited Financial ResultsJan 29, 2025
Jan 29, 2025Board Meeting Intimation for Standalone And Consolidated Unaudited Financial Results For The 3Rd Quarter And Nine Months Ended 31St December 2024Jan 14, 2025
Jan 14, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 08, 2025
Jan 08, 2025Change Of Name Of Registrar And Share Transfer Agent Of The CompanyJan 03, 2025
Jan 03, 2025Technical Indicators
RSI(14)
Neutral 63.58
ATR(14)
Less Volatile 9.96
STOCH(9,6)
Neutral 52.17
STOCH RSI(14)
Neutral 64.46
MACD(12,26)
Bullish 1.53
ADX(14)
Strong Trend 40.43
UO(9)
Bearish 41.61
ROC(12)
Uptrend And Accelerating 16.25
WillR(14)
Neutral -29.59
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
